Antiplatelet activity of deferiprone through cyclooxygenase-1 inhibition
Thalassemia patients are susceptible to both iron overload and thromboembolism. Deferiprone is an iron chelator that shows an antiplatelet activity and thus may alleviate platelet hyperactivation in thalassemia. Therefore, this study aimed to characterize the inhibitory effects and mechanisms of def...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2020-05-01
|
| Seri Bilgileri: | Platelets |
| Konular: | |
| Online Erişim: | http://dx.doi.org/10.1080/09537104.2019.1648782 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|